Cargando…
Fetal death in utero and miscarriage in a patient with Crohn’s disease under therapy with ustekinumab: case-report and review of the literature
BACKGROUND: Ustekinumab is a fully human monoclonal antibody against the p40 subunit of interleukin (IL) 12 and 23 which is involved in the pathogenesis of several inflammatory diseases. Ustekinumab is approved for psoriasis and psoriatic arthritis treatment and has been successfully evaluated in ph...
Autores principales: | Venturin, C., Nancey, S., Danion, P., Uzzan, M., Chauvenet, M., Bergoin, C., Roblin, X., Flourié, B., Boschetti, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477379/ https://www.ncbi.nlm.nih.gov/pubmed/28629323 http://dx.doi.org/10.1186/s12876-017-0633-6 |
Ejemplares similares
-
Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021) -
Relationships of circulating CD4(+) T cell subsets and cytokines with the risk of relapse in patients with Crohn’s disease
por: Duclaux-Loras, Rémi, et al.
Publicado: (2022) -
Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease
por: Roblin, Xavier, et al.
Publicado: (2023) -
Gonococcal Chorioamnionitis with Antepartum Fetal Death In Utero
por: Coutanceau, B., et al.
Publicado: (2015) -
Rapid Resolution of Vulvar Crohn's Disease With Ustekinumab
por: Stoleru, Gianna, et al.
Publicado: (2020)